Akinaru Yamamoto

7PUBLICATIONS
16CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMicrobial ecologyCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 23, 2026
Microbiome-Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers.

|Jan 20, 2026
Compound Library Screening Identified Cladribine as a Novel Radiosensitizer for Prostate Cancer.

Toshiki Oka, Koji Hatano, Shohei Katsuki

|Sep 16, 2025
Development of a Synthetic Lethality-Based Combination Therapy Using LIG1 and PARP Inhibitors for Prostate Cancer.

Masaru Tani, Koji Hatano, Yu Ishizuya

|Dec 18, 2024
A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure.

Akinaru Yamamoto, Atsunari Kawashima, Toshihiro Uemura

|Nov 20, 2024
Bacterial information in serum extracellular vesicles reflects the inflammation of adherent perinephric fat.

Toshihiro Uemura, Atsunari Kawashima, Kentaro Jingushi

|Nov 09, 2020
Advanced adrenocortical carcinoma successfully treated with gemcitabine plus capecitabine as second-line chemotherapy.

Akinaru Yamamoto, Yasutomo Nakai, Toshiki Oka

Pageof 2

Frequent Collaborators

5 joint publications

Norio Nonomura

4 joint publications

Atsunari Kawashima

3 joint publications

Kentaro Jingushi

3 joint publications

Taigo Kato